Translational Regenerative Medicines - Global Market Outlook (2017-2026)

Translational Regenerative Medicines - Global Market Outlook (2017-2026)

  • Published: May 2019
  • ID: SMRC18256

According to Stratistics MRC, the Global Translational Regenerative Medicines Market is growing at a CAGR of 13.9% from 2017 to 2026. Factors such as the increasing prevalence of degenerative diseases, rise in aging population and growing advancements in developed countries are the major driving factors. However, ethical concerns related to the use of embryonic stem cells in research & development hinders market growth.

Regenerative medicine is a segment of translational research in molecular biology and tissue engineering. It involves the process of regeneration of human cells, tissues, or organs to re-establish their normal functions through stimulation of the body’s repair system. They are widely used in the treatment of many degenerative disorders occurring in the areas of dermatology, orthopedic, cardiovascular and neurodegenerative diseases.

By Product Type, the Gene therapy segment is expected to have significant growth during the forecast period. Gene therapy assists the foundation for innovative treatments of innumerable musculoskeletal disorders. By geography, North America dominated the global regenerative medicine market owing to an increased number of leading companies and growth in the expansion of research and development activities in the U.S.

Some of the key players profiled in the Translational Regenerative Medicines Market include Vericel Corporation, Gamida Cell Ltd., Athersys, Inc., Orthofix International N.V, Anika Therapeutics, Novartis, Celgene Corporation, Brainstorm Cell Therapeutics Inc., Nuvasive, Inc., Medipost, 
CONMED Corporation, Arthrex Inc, Organogenesis Inc, Osiris Therapeutics, Inc, and Medtronic.

Product Types Covered:
• Cell-Based Products
• Tissue Engineered Products
• Gene Therapy Products

Applications Covered:
• Dermatology
• Cardiovascular
• Oncology
• Diabetes
• Orthopedic
• Neurology
• Other Applications

Regions Covered:
• North America 
o US
o Canada
o Mexico
• Europe 
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific 
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, , and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

 

1 Executive Summary         
           
2 Preface  
        
 2.1 Abstract         
 2.2 Stake Holders        
 2.3 Research Scope        
 2.4 Research Methodology       
  2.4.1 Data Mining       
  2.4.2 Data Analysis       
  2.4.3 Data Validation       
  2.4.4 Research Approach       
 2.5 Research Sources        
  2.5.1 Primary Research Sources      
  2.5.2 Secondary Research Sources      
  2.5.3 Assumptions       
           
3 Market Trend Analysis        
 3.1 Introduction        
 3.2 Drivers         
 3.3 Restraints        
 3.4 Opportunities        
 3.5 Threats         
 3.6 Product Analysis        
 3.7 Application Analysis       
 3.8 Emerging Markets        
 3.9 Futuristic Market Scenario       
           
4 Porters Five Force Analysis        
 4.1 Bargaining power of suppliers       
 4.2 Bargaining power of buyers        
 4.3 Threat of substitutes       
 4.4 Threat of new entrants       
 4.5 Competitive rivalry        
           
5 Global Translational Regenerative Medicines Market, By Product Type    
 5.1 Introduction        
 5.2 Cellular          
 5.3 Acellular         
           
6 Global Translational Regenerative Medicines Market, By Therapy    
 6.1 Introduction        
 6.2 Gene Therapy        
 6.3 Cell Therapy        
 6.4 Immunotherapy        
 6.5 Tissue Engineering        
           
7 Global Translational Regenerative Medicines Market, By Application    
 7.1 Introduction        
 7.2 Dermatology        
 7.3 Cardiovascular        
 7.4 Oncology         
 7.5 Diabetes         
 7.6 Orthopedic        
 7.7 Neurology        
 7.8 Other Applications        
           
8 Global Translational Regenerative Medicines Market, By Geography    
 8.1 Introduction        
 8.2 North America        
  8.2.1 US        
  8.2.2 Canada        
  8.2.3 Mexico        
 8.3 Europe          
  8.3.1 Germany        
  8.3.2 UK        
  8.3.3 Italy        
  8.3.4 France        
  8.3.5 Spain        
  8.3.6 Rest of Europe       
 8.4 Asia Pacific        
  8.4.1 Japan        
  8.4.2 China        
  8.4.3 India        
  8.4.4 Australia        
  8.4.5 New Zealand       
  8.4.6 South Korea       
  8.4.7 Rest of Asia Pacific       
 8.5 South America        
  8.5.1 Argentina       
  8.5.2 Brazil        
  8.5.3 Chile        
  8.5.4 Rest of South America      
 8.6 Middle East & Africa       
  8.6.1 Saudi Arabia       
  8.6.2 UAE        
  8.6.3 Qatar        
  8.6.4 South Africa       
  8.6.5 Rest of Middle East & Africa      
           
9 Key Developments         
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures    
 9.2 Acquisitions & Mergers       
 9.3 New Product Launch       
 9.4 Expansions        
 9.5 Other Key Strategies       
           
10 Company Profiling         
 10.1 Vericel Corporation        
 10.2 Gamida Cell Ltd.         
 10.3 Athersys, Inc.        
 10.4 Orthofix International N.V       
 10.5 Anika Therapeutics        
 10.6 Novartis         
 10.7 Celgene Corporation       
 10.8 Brainstorm Cell Therapeutics Inc.      
 10.9 Nuvasive, Inc.        
 10.10 Medipost         
 10.11 CONMED Corporation       
 10.12 Arthrex Inc        
 10.13 Organogenesis Inc        
 10.14 Osiris Therapeutics, Inc       
 10.15 Medtronic        


List of Tables          
1 Global Translational Regenerative Medicines Market Outlook, By Region (2016-2026) (US $MN)  
2 Global Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)  
3 Global Translational Regenerative Medicines Market Outlook, By Cellular  (2016-2026) (US $MN)  
4 Global Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)  
5 Global Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)  
6 Global Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)  
7 Global Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)  
8 Global Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN) 
9 Global Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN) 
10 Global Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)  
11 Global Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)  
12 Global Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)  
13 Global Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)  
14 Global Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)  
15 Global Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)  
16 Global Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)  
17 Global Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN) 
18 North America Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN) 
19 North America Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN) 
20 North America Translational Regenerative Medicines Market Outlook, By Cellular  (2016-2026) (US $MN) 
21 North America Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN) 
22 North America Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN) 
23 North America Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN) 
24 North America Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN) 
25 North America Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN) 
26 North America Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
27 North America Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN) 
28 North America Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN) 
29 North America Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN) 
30 North America Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN) 
31 North America Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN) 
32 North America Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN) 
33 North America Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN) 
34 North America Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
35 Europe Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)  
36 Europe Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)  
37 Europe Translational Regenerative Medicines Market Outlook, By Cellular  (2016-2026) (US $MN)  
38 Europe Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)  
39 Europe Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)  
40 Europe Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)  
41 Europe Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)  
42 Europe Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN) 
43 Europe Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN) 
44 Europe Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN)  
45 Europe Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)  
46 Europe Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)  
47 Europe Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)  
48 Europe Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)  
49 Europe Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN)  
50 Europe Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)  
51 Europe Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN) 
52 Asia Pacific Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN)  
53 Asia Pacific Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN) 
54 Asia Pacific Translational Regenerative Medicines Market Outlook, By Cellular  (2016-2026) (US $MN)  
55 Asia Pacific Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN)  
56 Asia Pacific Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN)  
57 Asia Pacific Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN) 
58 Asia Pacific Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN) 
59 Asia Pacific Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN) 
60 Asia Pacific Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN) 
61 Asia Pacific Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN) 
62 Asia Pacific Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN) 
63 Asia Pacific Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN) 
64 Asia Pacific Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN)  
65 Asia Pacific Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN)  
66 Asia Pacific Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN) 
67 Asia Pacific Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN)  
68 Asia Pacific Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN) 
69 South America Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN) 
70 South America Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN) 
71 South America Translational Regenerative Medicines Market Outlook, By Cellular  (2016-2026) (US $MN) 
72 South America Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN) 
73 South America Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN) 
74 South America Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN) 
75 South America Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN) 
76 South America Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN) 
77 South America Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
78 South America Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN) 
79 South America Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN) 
80 South America Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN) 
81 South America Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN) 
82 South America Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN) 
83 South America Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN) 
84 South America Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN) 
85 South America Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)
86 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Country (2016-2026) (US $MN) 
87 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Product Type (2016-2026) (US $MN)
88 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Cellular  (2016-2026) (US $MN) 
89 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Acellular (2016-2026) (US $MN) 
90 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Therapy (2016-2026) (US $MN) 
91 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Gene Therapy (2016-2026) (US $MN)
92 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Cell Therapy (2016-2026) (US $MN)
93 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Immunotherapy (2016-2026) (US $MN)
94 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Tissue Engineering (2016-2026) (US $MN)
95 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Application (2016-2026) (US $MN) 
96 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Dermatology (2016-2026) (US $MN)
97 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Cardiovascular (2016-2026) (US $MN)
98 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Oncology (2016-2026) (US $MN) 
99 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Diabetes (2016-2026) (US $MN) 
100 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Orthopedic (2016-2026) (US $MN) 
101 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Neurology (2016-2026) (US $MN) 
102 Middle East & Africa Translational Regenerative Medicines Market Outlook, By Other Applications (2016-2026) (US $MN)

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials